Biopharma Web Design: Biotech Websites That Survive Diligence and Regulatory Review

Five audiences, one URL, no second chances

A consumer brand's website has one reader to please. A clinical-stage company has five, and each arrives with a different question and a different tolerance for fluff. The investor wants stage, indication and cash runway context. The business development lead at a larger company wants to know whether your target is worth a call. The scientist wants to know if your platform is real. The patient wants to know if a trial is recruiting near them. The reporter wants a dated press release and a contact who answers.

Biotech website design, section by section

Most life science sites share a skeleton. What separates a good one is the order and the honesty: the pipeline before the platform pitch, real dates on everything, and no page that says more than your data can carry. This is the build list we start from for biotech website design, trimmed to the stage you are at.

A stealth or seed company may need only the first three rows and a contact. A company with a marketed product needs all of them, plus the review controls described below. For the wider argument about why biopharma credibility starts online, see our biopharma industry page; diagnostics and tools companies fit the biotech and life sciences page better.

What FDA's promotion rules mean for a company website

The Food and Drug Administration does not license websites, but it does police what a drug company says about its products. Within FDA's Center for Drug Evaluation and Research, the Office of Prescription Drug Promotion (OPDP) reviews prescription drug advertising and promotional labeling to help ensure it is truthful, balanced and accurately communicated, and it issues letters when it finds material false or misleading. These are the points our builds account for, as FDA describes them.

• Before approval. FDA's regulation at 21 CFR 312.7 says a sponsor, or anyone acting for it, may not represent in a promotional context that an investigational drug is safe or effective for the use under study, or otherwise promote it. The same rule says it does not restrict the full exchange of scientific information, including findings published in scientific or lay media. A pipeline page states stage, not promise.
• Balance. FDA's advertising regulation treats an ad as potentially misleading when risk information, such as side effects and contraindications, is not presented with prominence and readability reasonably comparable to the effectiveness claims. On a web page that is a layout question as much as a copy question.
• Risk disclosure in print-style materials. FDA has draft guidance (revised 2015) on the brief summary of risk information required in prescription drug advertising, aimed at consumer-directed print ads and promotional labeling.
• Claims about approval. OPDP's FAQ says a product may be called FDA-approved only when the sponsor has received an approval letter.
• Submissions. For approved products, promotional labeling goes to FDA on Form FDA 2253 at the time of initial dissemination. OPDP will comment on proposed material when a sponsor asks, but says preclearance is not required except in rare cases.
• Short formats. FDA has a 2014 draft guidance on presenting risk and benefit information on internet and social media platforms with character limits, relevant to meta descriptions, social cards and paid search text.

Review workflows that keep scientists and lawyers on the same page

Most biopharma website delays are not design delays. They are three reviewers editing three copies of a Word file while the launch date slides. We build the site so review happens in one place: drafts that can be previewed before anyone publishes, a history of every change with who approved it, and dates printed on pages where timing matters (pipeline updates, news, publications).

Athena CMS comes with every custom site we build, and its AI agents only draft; a person publishes. Calliope drafts articles and explainers for your scientists to correct, Iris handles titles, descriptions and structured data, Argus watches the site for broken pages and forms, and Harmonia checks accessibility. If your team is weighing a familiar alternative, read how Athena compares with WordPress.

A tour of the DataCram Therapeutics demonstration site

We built DataCram Therapeutics, a demonstration site for a fictional clinical-stage company, to show this approach rather than describe it. It is not client work, and it says so: a permanent amber bar above the masthead, a full disclosure in the footer, and the word fictional in the page title and description, so the notice travels with any screenshot or quote.

• A pipeline in real HTML. Five invented programs across discovery, IND-enabling, Phase 1 and Phase 2, each with target, indication and modality, shown as a table on desktop and as cards on phones, with a stage track that needs no JavaScript.
• Pipeline before platform. The programs come first, then the platform explained in a four-step diagram, from human data in to translational readout.
• Science and news, dated. A list of publications and preprints by year, and a newsroom of press releases, a publication and a congress presentation.
• Routes for business development. Separate partnering, investor and media contacts instead of one generic form.
• Restraint where it matters. No efficacy or safety results and no trial registry identifiers anywhere; leadership names are invented, the portraits are labeled AI-generated, and no credentials are claimed.
• Machine-readable honesty. The structured data describes a demonstration web page published by DataCram, with no organization markup for a company that does not exist.

It also comes in three hero treatments (photo backdrop, ambient video, white split layout) over one shared body, so first impressions can be compared fairly.

Speed, accessibility and the crawlers reading your pipeline

A pipeline locked in a PDF or an image is invisible to most of the software that now summarizes companies. Vercel's December 2024 analysis found that OpenAI's, Anthropic's and Perplexity's crawlers did not run JavaScript, so text that appears only after scripts load may never reach them. Our sites are built on Next.js and prerendered, which puts the pipeline, the publications and the news in the HTML itself. A well-built WordPress site serves HTML too; the risk sits in single-page builds and pipeline images. The details are in JavaScript and AI crawlers.

Accessibility matters twice here: patients and caregivers include people using screen readers and magnification, and investors read on phones. We build with real table markup for the pipeline, labeled forms, strong contrast and keyboard menus; the ADA compliance service adds a formal review against WCAG. Speed work is covered on Core Web Vitals. To see how ChatGPT and other engines describe your company today, run the free AI visibility check; structured data that matches the visible page is explained in structured data for AI.

Biopharma marketing after launch

Biopharma digital marketing rarely looks like retail marketing. The audience is small, expert and searching for an indication, a target or a mechanism rather than a brand. What works is content marketing your scientists sign off on, search work on the terms partners and analysts use, and, for companies recruiting patients or staff, carefully reviewed paid search. Ad text is short-format promotion, so it goes through the same reviewers as the site. Business-to-business firms that sell tools and services into pharma have a different playbook, covered on B2B website design.

Cost, financing and how a biotech site gets built

Custom builds and rebuilds are a fixed price starting at $1,750. A site with a portal or web app, such as a gated data room for partners or an investor login, starts at $3,500, and the web design pricing page puts a site with online booking or a request flow at about $9,000. Financing is 0% with 25% down: up to 12 months on any project, 24 months from $15,000 and 36 months from $20,000. A $9,000 site is $2,250 down and $562.50 a month for twelve months. Hosting and upkeep are available through our maintenance plans.

1. 1

   A free home page mockup

   Ask for a free mockup and we design your home page around your actual pipeline and platform, yours to keep.

2. 2

   A fixed quote

   Scope is agreed in writing, with a single price, after the mockup or a free site audit.

3. 3

   Content with your scientists

   Short interviews with the people who run each program, so descriptions are accurate before reviewers ever see them.

4. 4

   Build and review rounds

   We build on Next.js with Athena CMS, and your regulatory and legal reviewers approve each page in preview.

5. 5

   Launch without losing links

   We time launch away from financings and data readouts, keep or redirect every existing URL, and connect analytics.

When is a builder enough? A two-person company in stealth with one program, no investor relations and no product may be fine on Squarespace for a year. Our Squarespace comparison is honest about that. Once you have a pipeline, publications and several kinds of visitor, a custom build earns its price. Browse other industries from the website design hub.